Patent Yard Sign in
Canadian application, no grantCanada

Assays for inhibitors of leukocyte adhesion

CA 2109212 A1 · Owner: Yednock, Ted · Inventors: Singer, Mark; Rosen, Steven; Imai, Yasuyuki

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides novel assays for determining the ability of a test compound to inhibit intercellular adhesion mediated by a selectin receptor, such as the LHR. The assays involve contacting the test compound with the receptor and an isolated receptor-binding agent. The receptor-binding agent is a sulfated polysaccharide, a sulfated glycolipid, or a compound comprising the extracellular region of an endothelial cell surface glycoprotein. Also provided are compositions comprising a compound comprising the extracellular region of an endothelial cell surface protein which is specifically recognized by lymphocyte homing receptors.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 1, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 1, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 1, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 1, 1992
GrantedNo grant recorded
Term endedMay 1, 2012
Patent numberCA 2109212 A1
Classification (IPC)G01N33/56 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedMay 1, 1992Term endedMay 1, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.